Cogent Biosciences, Inc.
COGT
$34.25
-$0.12-0.35%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 130.44% | 64.34% | -3.18% | -14.43% | -14.44% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 50.93% | -11.26% | -0.87% | -23.12% | 56.35% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 129.17% | 62.14% | -3.11% | -14.70% | -13.19% |
|
|
|||||
| Total Current Assets | 129.17% | 62.14% | -3.11% | -14.70% | -13.19% |
| Net Property, Plant & Equipment | -1.38% | -4.34% | -4.24% | -1.93% | -3.74% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -22.95% | -0.78% | 0.00% | 0.00% | 0.00% |
| Total Assets | 120.13% | 54.99% | -3.16% | -13.45% | -14.61% |
|
|
|||||
| Total Accounts Payable | -40.71% | -3.58% | 17.46% | 17.82% | -20.24% |
| Total Accrued Expenses | 6.78% | 11.22% | 17.53% | -20.81% | 15.48% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -9.32% | 2.90% | 2.92% | 2.94% | 2.96% |
| Total Finance Division Other Current Liabilities | 424.90% | 0.94% | 163.02% | 29.76% | 21.90% |
| Total Other Current Liabilities | 424.90% | 0.94% | 163.02% | 29.76% | 21.90% |
| Total Current Liabilities | 2.74% | 6.55% | 18.46% | -11.47% | 5.02% |
|
|
|||||
| Total Current Liabilities | 2.74% | 6.55% | 18.46% | -11.47% | 5.02% |
| Long-Term Debt | 403.72% | 0.68% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -1.70% | -2.98% | -2.77% | -2.65% | -2.50% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -98.61% | 0.47% | 47,080.00% | -- | -- |
| Total Liabilities | 143.98% | 3.08% | 84.84% | -9.51% | 3.25% |
|
|
|||||
| Common Stock & APIC | 35.52% | 21.69% | 0.96% | 3.72% | 1.01% |
| Retained Earnings | -9.44% | -8.05% | -7.89% | -8.38% | -8.58% |
| Treasury Stock & Other | 70.67% | 1,500.00% | -92.07% | -63.31% | -50.11% |
| Total Common Equity | 181.15% | 312.87% | -57.48% | -23.93% | -28.61% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -17.16% | 0.00% | -0.23% | -2.20% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -17.16% | 0.00% | -0.23% | -2.20% | 0.00% |
|
|
|||||
| Total Common Equity | 181.15% | 312.87% | -57.48% | -23.93% | -28.61% |
| Total Preferred Equity | -17.16% | 0.00% | -0.23% | -2.20% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 110.40% | 95.09% | -29.21% | -14.55% | -18.55% |
|
|
|||||